| Literature DB >> 36247120 |
Laverdure Tchamani Piame1, Pierre Marie Kaktcham1, Edith Marius Foko Kouam1, Ulrich Daquain Fotso Techeu1, Romial Joel Ngouénam1, François Zambou Ngoufack1.
Abstract
The current trend in starter selection is to combine both technological and probiotic properties to standardise and make functional artisanal fermented beverages such as Sha'a whose properties are very variable due to the lack of a known starter. The objective of this work was to study technological and probiotic properties of yeasts isolated from Sha'a sold in Bamenda, Bafoussam, Bonabérie, Dschang, Foumbot, Mbouda and Njombé (Cameroon). The isolated yeasts were studied for their ability to produce CO2 from glucose, to grow in the presence of 8% ethanol, 20% glucose and pH 3, to assimilate maltose and to produce ethanol. Then, the survival of the pre-selected isolates was assessed in simulated gastric (pH 2 and 3) and intestinal juices, followed by self-aggregation, co-aggregation, hydrophobicity, haemolysin, gelatinase, biogenic amine production, antibiotic and antifungal susceptibility, bile salt hydrolase and antiradical activity. The selected isolates were identified by sequencing the 5.8S/28S rRNA gene. From the 98 isolates obtained, 66 produced CO2 from glucose and 16 were then selected for their ability to grow in the presence of 8% ethanol, 20% glucose, pH 3 and maltose. The overall survival of isolates ranged from 4.12 ± 1.63 to 104.25 ± 0.19% (LT16) and from 0.56 ± 0.20 to 96.74 ± 1.60% (LT66) at pH 3 and pH 2 respectively. All of them have remarkable surface hydrophobicity properties. Based on principal component analysis, 5 isolates were selected as the best. However, only 3 of them, LT16 (the most promising), LT25 identified as Saccharomyces cerevisiae and LT80 as Nakaseomyces delphensis, do not produce a virulence factor. The latter can deconjugate bile salts with a maximum percentage of 60.54 ± 0.12% (LT16) and the highest inhibition of DPPH° radicals was 55.94 ± 1.14% (LT25). In summary, the yeast flora of Sha'a contains yeasts capable of fermenting and producing ethanol while producing bioactive compounds that would benefit the consumer.Entities:
Keywords: Bioactive compounds; Ethanol; Fermentation; Probiotic properties; Sha'a; Technological properties; Yeast
Year: 2022 PMID: 36247120 PMCID: PMC9557902 DOI: 10.1016/j.heliyon.2022.e10850
Source DB: PubMed Journal: Heliyon ISSN: 2405-8440
Ability of isolates to grow under different stress conditions, to produce ethanol and assimilate maltose.
| Isolates | Ethanol (g.l−1) | Ethanol 8% (rOD>2) | Glucose 20% (rOD>4) | pH3 (rOD>2) | Maltose assimilation (rOD) | Origins |
|---|---|---|---|---|---|---|
| LT1 | 34.50 ± 0.00g | 5.40 ± 0.02 | 10.67 ± 0.04 | 5.92 ± 0.40 | 9.69 ± 0.03 | Bamenda |
| LT3 | 40.91 ± 0.82d | 3.83 ± 0.02 | 10.71 ± 0.09 | 2.13 ± 0.11 | 9.92 ± 0.01 | |
| LT4 | 45.95 ± 1.38abc | 4.14 ± 0.01 | 9.24 ± 0.05 | 2.17 ± 0.13 | 8.80 ± 0.06 | |
| LT11 | 38.65 ± 0.03de | 3.33 ± 0.03 | 11.65 ± 0.16 | 2.17 ± 0.08 | 11.62 ± 0.03 | |
| LT16 | 23.95 ± 0.75g | 2.08 ± 0.04 | 12.95 ± 0.01 | 6.81 ± 0.03 | 9.73 ± 0.04 | |
| LT22 | 38.64 ± 0.33de | 2.60 ± 0.02 | 9.47 ± 0.08 | 4.93 ± 1.05 | 8.37 ± 0.04 | Bonabérie |
| LT25 | 34.79 ± 0.56f | 3.31 ± 0.01 | 8.75 ± 0.11 | 4.88 ± 0.90 | 6.09 ± 0.02 | |
| LT80 | 35.27 ± 0.28f | 2.98 ± 0.02 | 4.23 ± 0.08 | 5.33 ± 1.10 | 8.33 ± 0.01 | |
| LT30 | 48.32 ± 3.29a | 5.50 ± 0.03 | 8.36 ± 0.06 | 7.93 ± 0.00 | 7.38 ± 0.06 | |
| LT53 | 39.95 ± 0.42de | 2.52 ± 0.07 | 6.10 ± 0.00 | 3.73 ± 0.06 | 4.09 ± 0.39 | Dschang |
| LT54 | 25.27 ± 0.37g | 2.15 ± 0.06 | 6.43 ± 0.07 | 3.07 ± 0.45 | 5.78 ± 0.07 | |
| LT62 | 37.89 ± 0.89e | 2.56 ± 0.01 | 9.93 ± 0.02 | 1.64 ± 0.03 | 9.42 ± 0.00 | Bafoussam |
| LT66 | 43.93 ± 1.24c | 2.99 ± 0.06 | 10.87 ± 0.07 | 2.88 ± 0.11 | 9.93 ± 0.00 | |
| LT70 | 45.57 ± 0.61bc | 3.39 ± 0.07 | 10.58 ± 0.05 | 4.09 ± 0.58 | 9.92 ± 0.05 | |
| LT72 | 46.74 ± 0.90ab | 2.29 ± 0.04 | 7.04 ± 0.07 | 2.74 ± 0.35 | 10.05 ± 0.01 | |
| LT76 | 43.68 ± 0.74c | 3.74 ± 0.06 | 6.89 ± 0.09 | 2.10 ± 0.09 | 8.92 ± 0.00 |
a-g Within the same column, values with different lower case letters differ significantly (p < 0.05); i: initial, f: final.
Survival percentage of isolates at different pH of simulated gastric juices (SGJ) and intestinal juices (SIJ).
| Isolates | Viable count (log CFU/ml) | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| SGJ, pH 3 | SIJ, pH 7.4 | Overall survival (%) | SGJ, pH 2 | SIJ, pH 7.4 | Overall survival (%) | |||||||
| 0 min | 120 min | Survival (%) | 180 min | Survival (%) | 0 min | 120 min | Survival (%) | 180 min | Survival (%) | |||
| LT1 | 7.14 ± 0.00 | 6.74 ± 0.00 | 39.39 ± 0.08f | 6.31 ± 0.01 | 37.34 ± 0.55g | 14.71 ± 0.19hA | 7.07 ± 0.01 | 6.18 ± 0.02 | 12.91 ± 0.87g | 4.80 ± 0.14 | 4.31 ± 1.25h | 0.56 ± 0.20hiB |
| LT3 | 7.08 ± 0.00 | 6.98 ± 0.02 | 81.21 ± 2.07bc | 6.95 ± 0.00 | 91.49 ± 4.50cd | 74.23 ± 1.76dA | 7.17 ± 0.14 | 7.23 ± 0.00 | 92.26 ± 3.24ab | 7.15 ± 0.03 | 84.08 ± 4.40bc | 77.55 ± 6.78bcA |
| LT4 | 7.06 ± 0.00 | 7.05 ± 0.00 | 97.64 ± 0.02a | 6.68 ± 0.01 | 42.60 ± 0.18g | 41.59 ± 0.19eA | 7.12 ± 0.08 | 7.15 ± 0.00 | 95.58 ± 2.64a | 5.48 ± 0.05 | 2.17 ± 0.24h | 2.07 ± 0.29hiB |
| LT11 | 6.97 ± 0.00 | 6.87 ± 0.03 | 79.87 ± 3.75c | 6.17 ± 0.03 | 20.01 ± 2.69h | 15.92 ± 1.39gA | 6.85 ± 0.17 | 6.65 ± 0.05 | 81.22 ± 7.36c | 5.85 ± 0.02 | 15.92 ± 1.18g | 12.89 ± 0.22fgA |
| LT16 | 6.97 ± 0.00 | 6.96 ± 0.00 | 98.98 ± 0.08a | 6.99 ± 0.00 | 105.33 ± 0.10a | 104.25 ± 0.19aA | 7.05 ± 0.12 | 7.10 ± 0.01 | 91.03 ± 5.18ab | 7.08 ± 0.00 | 95.45 ± 2.80a | 86.78 ± 2.40bB |
| LT22 | 7.08 ± 0.00 | 6.99 ± 0.00 | 81.01 ± 1.09bc | 6.95 ± 0.01 | 92.21 ± 1.90bcd | 74.69 ± 0.53dA | 7.05 ± 0.04 | 6.93 ± 0.04 | 79.13 ± 4.36c | 6.80 ± 0.01 | 72.70 ± 6.08de | 57.35 ± 1.65dB |
| LT25 | 7.07 ± 0.00 | 7.06 ± 0.00 | 98.68 ± 0.06a | 7.03 ± 0.01 | 92.25 ± 2.42bcd | 91.03 ± 2.44bA | 7.07 ± 0.00 | 7.06 ± 0.00 | 96.66 ± 0.44a | 7.02 ± 0.01 | 90.14 ± 0.78ab | 87.12 ± 0.36bA |
| LT30 | 7.08 ± 0.01 | 7.06 ± 0.00 | 96.33 ± 1.85a | 7.03 ± 0.00 | 93.10 ± 0.82bcd | 89.66 ± 2.52bA | 6.88 ± 0.28 | 6.68 ± 0.03 | 95.39 ± 1.66a | 6.57 ± 0.05 | 78.49 ± 14.30cd | 74.40 ± 12.33cA |
| LT53 | 7.00 ± 0.00 | 6.79 ± 0.01 | 61.00 ± 1.63d | 6.55 ± 0.06 | 58.65 ± 6.36f | 35.82 ± 4.83fA | 7.00 ± 0.01 | 6.78 ± 0.01 | 60.41 ± 0.35d | 6.58 ± 0.01 | 64.06 ± 2.33e | 38.69 ± 1.63eA |
| LT54 | 7.06 ± 0.00 | 6.07 ± 0.02 | 10.08 ± 0.62g | 6.00 ± 0.05 | 16.11 ± 5.61i | 8.69 ± 1.10hA | 6.93 ± 0.19 | 5.22 ± 0.15 | 2.69 ± 0.97h | 0.00 ± 0.00 | 0.00 ± 0.00h | 0.00 ± 0.00iB |
| LT62 | 7.06 ± 0.00 | 6.99 ± 0.00 | 85.15 ± 0.41b | 6.95 ± 0.01 | 90.43 ± 0.84d | 77.00 ± 0.35dA | 6.98 ± 0.11 | 6.85 ± 0.00 | 86.13 ± 2.95bc | 6.83 ± 0.00 | 94.49 ± 0.23a | 81.35 ± 2.98bcA |
| LT66 | 7.30 ± 0.00 | 7.22 ± 0.02 | 83.43 ± 4.10bc | 7.22 ± 0.00 | 100.36 ± 4.52abc | 83.63 ± 0.34cB | 7.29 ± 0.01 | 7.28 ± 0.00 | 97.54 ± 1.43a | 7.27 ± 0.00 | 99.18 ± 0.19a | 96.74 ± 1.60aA |
| LT70 | 7.13 ± 0.01 | 6.87 ± 0.00 | 55.61 ± 4.26e | 6.71 ± 0.00 | 69.07 ± 0.15e | 38.31 ± 2.86efA | 6.94 ± 0.26 | 6.37 ± 0.01 | 40.92 ± 2.56f | 6.09 ± 0.03 | 51.78 ± 1.29f | 21.18 ± 1.85fB |
| LT72 | 7.04 ± 0.01 | 6.62 ± 0.01 | 38.89 ± 1.66f | 5.63 ± 0.16 | 10.59 ± 3.75i | 4.12 ± 1.63hA | 6.93 ± 0.15 | 5.06 ± 0.08 | 1.62 ± 0.14h | 3.55 ± 0.21 | 3.17 ± 0.95h | 0.05 ± 0.02iA |
| LT76 | 6.95 ± 0.00 | 6.76 ± 0.01 | 64.23 ± 1.53d | 6.47 ± 0.00 | 52.38 ± 1.41f | 33.63 ± 0.10fA | 6.96 ± 0.02 | 6.67 ± 0.01 | 49.06 ± 1.33e | 5.97 ± 0.05 | 20.02 ± 1.99g | 9.83 ± 1.24ghB |
| LT80 | 7.03 ± 0.01 | 7.03 ± 0.03 | 100.22 ± 2.51a | 7.03 ± 0.01 | 101.05 ± 9.68ab | 100.99 ± 7.16aA | 7.03 ± 0.01 | 7.01 ± 0.00 | 97.20 ± 7.35a | 7.00 ± 0.00 | 98.92 ± 0.15a | 95.90 ± 7.42aA |
a-i On the same column, values with lower case letters differ significantly (p < 0.05); A−B On the same row, values with lower case letters differ significantly (p < 0.05); CFU: Colony forming unit; SGJ: Simulated gastric juice; SIJ: Simulated intestinal juice.
Percentage of adherence to hydrocarbons, self-aggregation and co-aggregation of pre-selected yeast isolates.
| Isolates | Auto-aggregation 2h (%) | Auto-aggregation 4h (%) | Coaggregation (%) | Hex (%) | Chl (%) |
|---|---|---|---|---|---|
| LT1 | 93.44 ± 0.16bcA | 93.48 ± 1.01bA | 46.12 ± 1.81g | 2.05 ± 0.32kB | 26.37 ± 0.54jA |
| LT3 | 90.29 ± 0.32efA | 89.69 ± 0.33gA | 47.78 ± 0.21f | 4.68 ± 0.30jB | 86.36 ± 0.15aA |
| LT4 | 92.61 ± 0.26cdA | 92.56 ± 0.09cdA | 44.95 ± 0.57g | 19.91 ± 0.42fA | 19.76 ± 1.05lA |
| LT11 | 93.81 ± 0.27abA | 93.76 ± 0.46abA | 48.47 ± 0.28ef | 27.87 ± 0.45dA | 21.66 ± 0.23hB |
| LT16 | 94.72 ± 0.35aA | 94.53 ± 0.03aA | 47.97 ± 0.40f | 36.70 ± 0.69aB | 86.06 ± 0.42aA |
| LT22 | 92.24 ± 0.43dA | 92.43 ± 0.29deA | 54.89 ± 0.13b | 15.98 ± 0.90gB | 72.96 ± 0.82eA |
| LT25 | 86.93 ± 0.24gB | 93.42 ± 0.19bA | 50.54 ± 0.55d | 21.49 ± 0.21eB | 79.33 ± 0.53bA |
| LT30 | 86.06 ± 0.18gB | 92.20 ± 0.19deA | 49.26 ± 0.06e | 18.72 ± 0.21fA | 11.44 ± 1.05mB |
| LT53 | 92.53 ± 0.17cdA | 91.64 ± 0.24efA | 38.18 ± 0.17i | 9.82 ± 0.19iAB | 74.83 ± 1.06dA |
| LT54 | 77.43 ± 1.13iB | 90.26 ± 0.14gA | 52.90 ± 0.07c | 10.90 ± 0.80ihB | 77.26 ± 0.00cA |
| LT62 | 71.64 ± 0.87kB | 90.31 ± 0.49gA | 50.93 ± 0.37d | 28.23 ± 1.26dB | 66.94 ± 0.95fA |
| LT66 | 73.09 ± 0.40jB | 90.13 ± 0.20gA | 47.79 ± 0.12f | 31.58 ± 0.51cB | 39.45 ± 0.82hA |
| LT70 | 89.62 ± 0.74fB | 91.34 ± 0.19fA | 45.67 ± 0.15g | 12.02 ± 0.00hB | 66.36 ± 0.43fA |
| LT72 | 90.99 ± 0.05eA | 90.15 ± 0.35gB | 53.12 ± 0.31c | 32.95 ± 1.03bA | 28.37 ± 0.51iA |
| LT76 | 94.11 ± 0.55abA | 93.31 ± 0.01bcA | 40.61 ± 0.77h | 10.27 ± 0.22iB | 41.15 ± 0.34gA |
| LT80 | 83.05 ± 0.16hB | 87.55 ± 0.46hA | 58.24 ± 0.16a | 28.24 ± 0.43dA | 25.93 ± 0.14jB |
a-m In the same column, values with lower case letters differ significantly (p < 0.05); A−B In the same row, values with lower case letters differ significantly (p < 0.05); Hex: hexane; Chl: chloroform.
Contribution of variables to PCA factors based on correlation.
| F1 | F2 | F3 | F4 | F5 | F6 | F7 | |
|---|---|---|---|---|---|---|---|
| Survival pH3 | 0.786 | 0.510 | 0.164 | -0.175 | 0.219 | 0.038 | -0.122 |
| Survival pH2 | 0.864 | 0.432 | 0.041 | -0.189 | 0.106 | -0.017 | 0.134 |
| Auto-agregation 2h (%) | -0.689 | 0.347 | 0.341 | 0.222 | 0.400 | -0.283 | 0.015 |
| Auto-agregation 4h (%) | -0.555 | 0.554 | 0.472 | 0.110 | -0.161 | 0.351 | 0.017 |
| Co-agregation (%) | 0.654 | -0.413 | 0.099 | 0.521 | 0.285 | 0.197 | 0.010 |
| Hexane (%) | 0.572 | -0.122 | 0.652 | 0.167 | -0.394 | -0.223 | -0.009 |
| Chloroform (%) | 0.180 | 0.621 | -0.581 | 0.433 | -0.220 | -0.088 | -0.011 |
Figure 1Projection of the variables and yeast isolates onto the plane formed by the two factors obtained by PCA. Hex: hexane; Chl: chloroform; Ag2h (4 h): auto-agrégation after 2 h (or 4 h); CoA: Co-aggregation; SGJ-pH3-SIJ: simulated gastric juice at pH3 follow by simulated intestinal juice; SGJ-pH2-SIJ: simulated gastric juice at pH 2 followed by simulated intestinal juice.
Presence or absence of biogenic amine, hemolysin and gelatinase production and their susceptibility to antibiotics.
| Isolates | Antibiotics | Antifungals | Heamolysin | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Amox | Erhy | Cipro | Genta | Tetra | Levo | Nysta | Fluco | Itra | β-heamolysis | α-heamolysis | |
| LT3 | R | R | R | R | R | R | S | S | S | - | + |
| LT16 | R | R | R | R | R | R | S | S | S | - | - |
| LT22 | R | R | R | R | R | R | S | S | S | - | + |
| LT25 | R | R | R | R | R | R | S | S | S | - | - |
| LT80 | R | R | R | R | R | R | S | S | S | - | - |
Amox: amoxicillin, Ery: erythromycin, Cipro: ciprofloxacin, Genta: gentamicin, Tetra: tetracyclin, Ampi: ampicillin, Levo: levofloxacin, Fluco: fluconazol, Itra: itraconazol, Fluoro: fluorocytosin, Anud: anudilafungin, Ampho: amphotericin B, Nyst: nystatin.
Figure 2Hydrolysis of bile salts on Yeast extract Peptone Glucose agar plate presenting clear and opaque areas around the spots.
Bile salt hydrolase and antiradical activities of supernatants and intracellular contents of selected isolates.
| Isolates | Supernatant | ICC | Reduction of DPPH° (%) of supernatants | Reduction of DPPH° (%) of ICC | Reduction of DPPH° (%) of cells | ||
|---|---|---|---|---|---|---|---|
| Enzymatic activity (μg of bile salt/ml/min) | Amino acid (%) | Enzymatic activity (μg of bile salt/ml/min) | Amino acid (%) | ||||
| LT16 | 1.02 ± 0.00cB | 20.36 ± 0.12cB | 3.06 ± 0.02aA | 60.54 ± 0.12aA | 46.58 ± 1.42bB | 13.02 ± 0.55cC | 0.00 ± 0.00cC |
| LT25 | 2.12 ± 0.00aA | 41.99±0aA | 0 ± 0.00bB | 0 ± 0.00bB | 55.94 ± 1.14aA | 24.26 ± 0.49aA | 12.64 ± 0.02aA |
| LT80 | 1.84 ± 0.00bA | 38.54 ± 1.8bA | 0 ± 0.00bB | 0 ± 0.00bB | 34.56 ± 1.07cC | 22.86 ± 1.24bB | 11.30 ± 0.04bB |
a-c On the same column, values with lower case letters differ significantly (p < 0.05); A−C On the same row for a given activity, values with higher case letters differ significantly (p < 0.05); ICC: IntraCellular Content.